Experience

• • Valenz Health, a Kelso & Company portfolio company and platform of integrated cost containment and payment integrity solutions, in its acquisition of Healthcare Bluebook, a healthcare cost and quality navigation platform.
  • Gentiva, a Clayton, Dubilier & Rice portfolio company, in the sale of its personal care operations to Addus in a transaction valued at approximately $350 million.
  • Cerberus Capital Management in its $640 million sale of Cyanco to Orica.
  • Clayton, Dubilier & Rice in its strategic partnership with Elevance Health, which will bring together certain care delivery and enablement assets of Elevance’s Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group.
  • Kelso & Company in its investment in Valenz.
  • Pernod Ricard in its acquisition of a majority stake in Skrewball, a super-premium and fast-growing flavored whiskey.
  • Gentiva, a Clayton, Dubilier & Rice portfolio company and leading hospice, palliative, and personal care company, in its acquisition of Heartland hospice and home care.
  • Dover Corporation in its $225 million acquisition of Malema, a designer and manufacturer of flow-measurement and control instruments for the biopharmaceutical, semiconductor, and industrial sectors.
  • Clayton, Dubilier & Rice in its acquisition of a 60% interest in Humana’s Kindred at Home Hospice and Personal Care divisions, valued at $3.4 billion.
  • Mizuho, a leading global bank, in its acquisition of Capstone Partners, a leading middle-market placement agent.